BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2601000)

  • 1. A digoxin-like immunoreactive substance and atrioventricular block induced by a Chinese medicine "kyushin".
    Lin CS; Lin MC; Chen KS; Ho CC; Tsai SR; Ho CS; Shieh WH
    Jpn Circ J; 1989 Sep; 53(9):1077-80. PubMed ID: 2601000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Chinese medicine "kyushin" on serum digoxin concentration measurement in dogs.
    Lin CS; Lin MC; Chen KS; Liu CB
    Jpn Circ J; 1989 Feb; 53(2):108-12. PubMed ID: 2716172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological actions of "kyushin," a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration.
    Morishita S; Shoji M; Oguni Y; Ito C; Higuchi M; Sakanashi M
    Am J Chin Med; 1992; 20(3-4):245-56. PubMed ID: 1471608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of self-induced digoxin poisoning: with His bundle studies of the site of heart block.
    Chan W; Ikram H
    N Z Med J; 1976 Dec; 84(577):443-6. PubMed ID: 1071160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin automated immunoassay.
    Lacarelle B; Durand A; Labadie N; Cano JP
    Ther Drug Monit; 1989 Nov; 11(6):725-7. PubMed ID: 2595757
    [No Abstract]   [Full Text] [Related]  

  • 6. Digoxin-like immunoreactivity: is it still worth measuring?
    Goto A; Yamada K; Yagi N; Hui C; Sugimoto T
    Life Sci; 1991; 49(23):1667-78. PubMed ID: 1658518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA; Godley PJ; Frohna PA; Horton MW; Reitmeyer WJ
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad.
    Bagrov AY; Roukoyatkina NI; Fedorova OV; Pinaev AG; Ukhanova MV
    Eur J Pharmacol; 1993 Apr; 234(2-3):165-72. PubMed ID: 8387009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin-like substance in amniotic fluid--fact or artifact?
    Greenway DC; Nanji AA
    Gynecol Obstet Invest; 1986; 22(2):108-9. PubMed ID: 3770531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary electrolytes and urinary natriuretic factors.
    Ho CS; Ho SC; Swaminathan R
    Int J Cardiol; 1993 Apr; 39(1):1-4. PubMed ID: 8407003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive substance in renal failure.
    Seyrek N; Paydas S; Sargin O; Günday V; Sağliker Y
    Nephron; 1994; 67(2):253-4. PubMed ID: 8072625
    [No Abstract]   [Full Text] [Related]  

  • 13. Wenckebach type H-V block induced by digitalis intoxication.
    Rostás L; Tarján J
    Z Kardiol; 1980 Nov; 69(11):779-81. PubMed ID: 7467660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toad venom poisoning: failure of a monoclonal digoxin immunoassay to cross-react with the cardioactive steroids.
    Brubacher JR; Hoffman RS; Kile T
    J Toxicol Clin Toxicol; 1996; 34(5):529-30. PubMed ID: 8800193
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of gestational age and preeclampsia on the presence and magnitude of serum endogenous digoxin-like immunoreactive substance(s).
    Phelps SJ; Cochran EB; Gonzalez-Ruiz A; Tolley EA; Hammond KD; Sibai BM
    Am J Obstet Gynecol; 1988 Jan; 158(1):34-9. PubMed ID: 3337179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration of digoxin-like immunoreactive substance in patients with preeclampsia and its relation to severity of pregnancy-induced hypertension.
    Kaminski K; Rechberger T
    Am J Obstet Gynecol; 1991 Sep; 165(3):733-6. PubMed ID: 1892203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like immunoreactive substance in fetuses with and without cardiac pathology.
    Weiner CP; Landas S; Persoon TJ
    Am J Obstet Gynecol; 1987 Aug; 157(2):368-71. PubMed ID: 3618686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of toad venom poisoning with digoxin-specific Fab fragments.
    Brubacher JR; Ravikumar PR; Bania T; Heller MB; Hoffman RS
    Chest; 1996 Nov; 110(5):1282-8. PubMed ID: 8915235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of digoxin-like immunoreactive substance cross-reactivity with two digoxin immunoassays in normotensive third trimester pregnancy.
    Phelps S; Hammond K; Bottorff M; Sibai B
    Ther Drug Monit; 1987 Dec; 9(4):489. PubMed ID: 3424417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.